ABT Competitors
Abbott Laboratories
$104.89
+$0.21(+0.20%)
63
Overall
90
Value
54
Tech
47
Quality
Market Cap
$181.50B
Volume
8.24M
52W Range
$81.97 - $132.03
Target Price
$120.74
ABT competitors: JNJ, PFE, MDT, TMO, BMY. Abbott Laboratories is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ABT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| JNJ Johnson & Johnson | $255.56 | $615.87B | $11.10 | 2.07% | 46 |
| PFE Pfizer Inc. | $29.58 | $168.60B | $2.96 | 5.81% | 70 |
| MDT Medtronic plc | $94.75 | $121.20B | $5.98 | 3.02% | 75 |
| TMO Thermo Fisher Scientific Inc. | $690.00 | $255.13B | $25.13 | 0.27% | 69 |
| BMY Bristol-Myers Squibb Company | $59.75 | $122.05B | $6.80 | 4.22% | 60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABT | $104.89 | +0.2% | 8.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |